These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1558156

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH, Rossing P, Hommel E, Smidt UM.
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Captopril augments the renal response to an amino acid infusion in diabetic adults.
    Slomowitz LA, Hirschberg R, Kopple JD.
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F755-62. PubMed ID: 3052112
    [Abstract] [Full Text] [Related]

  • 27. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ, Ramos OL, Gross JL.
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [Abstract] [Full Text] [Related]

  • 28. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS.
    Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
    [Abstract] [Full Text] [Related]

  • 29. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
    Osei SY, Price DA, Fisher ND, Porter L, Laffel LM, Hollenberg NK.
    Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity.
    Hansen PM, Mathiesen ER, Kofoed-Enevoldsen A, Deckert T.
    J Diabetes Complications; 1995 Jan; 9(3):158-62. PubMed ID: 7548979
    [Abstract] [Full Text] [Related]

  • 33. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW, Klein F, Christensen PD, Sørensen K, Andersen PH, Møller J, Pedersen EB, Christiansen JS, Mogensen CE.
    Diabete Metab; 1994 Jan; 20(5):485-93. PubMed ID: 7859897
    [Abstract] [Full Text] [Related]

  • 34. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ, Struijker-Boudier HA, Smits JF.
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [Abstract] [Full Text] [Related]

  • 35. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect.
    Rudberg S, Aperia A, Freyschuss U, Persson B.
    Diabetologia; 1990 Aug; 33(8):470-6. PubMed ID: 2170218
    [Abstract] [Full Text] [Related]

  • 36. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus.
    Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M.
    Kidney Int; 1988 Jan; 33(1):100-6. PubMed ID: 3352157
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA, Cowan P, Patrick AW, Clarke BF.
    Nephrol Dial Transplant; 1993 Jan; 8(3):200-5. PubMed ID: 8385284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.